In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), ...
Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).
The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.
Reviewed by David KindnessReviewed by David Kindness Pfizer Inc. (PFE) is a leading global biopharmaceutical company based in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback